Amide Overview
- Year Founded
-
2016
- Status
-
Private
- Employees
-
10
- Latest Deal Type
-
Series A
- Latest Deal Amount
-
$11M
- Investors
-
5
Amide General Information
Description
Provider of custom peptide synthesis services intended to facilitate advancements in drug discovery. The company offers reliable linear synthesis of peptides with extensive amino acid sequences, a prompt turnaround time, and a strong on-time delivery rate, enabling researchers and pharmaceutical companies to accelerate their drug development processes while accessing complex compounds that are often difficult to obtain.
Contact Information
Website
www.amidetech.comCorporate Office
- 300 2nd Avenue
- Floor 1
- Waltham, MA 02451
- United States
Corporate Office
- 300 2nd Avenue
- Floor 1
- Waltham, MA 02451
- United States
Amide Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Later Stage VC (Series A) | 01-Jul-2023 | $11M | Completed | Generating Revenue | ||
| 2. Accelerator/Incubator | 01-Sep-2022 | Completed | Startup | |||
| 1. Seed Round | 27-Nov-2017 | $5.45M | $5.45M | Completed | Startup |
Amide Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A-2 | ||||||||
| Series A-1 | ||||||||
| Series A | 9,000,099 | $0.000100 | $1 | $1 | $1 | 1x | $1 | 20.46% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Amide Comparisons
Industry
Financing
Details
Amide Competitors (4)
One of Amide’s 4 competitors is GenScript, a Formerly VC-backed company based in Nanjing, China.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| GenScript | Formerly VC-backed | Nanjing, China | ||||
| Enamine | Corporation | Kyiv, Ukraine | ||||
| AnaSpec | Corporate Backed or Acquired | Fremont, CA | ||||
| Polypeptide Laboratories | Corporation | Hoofddorp, Netherlands |
Amide Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Amide Patents
Amide Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4582441-A2 | Multimeric polypeptides and uses thereof | Pending | 12-Dec-2023 | ||
| EP-4582441-A3 | Multimeric polypeptides and uses thereof | Pending | 12-Dec-2023 | ||
| US-20250236656-A1 | Multimeric polypeptides and uses thereof | Pending | 12-Dec-2023 | ||
| US-11834480-B2 | Protein inhibitors with reduced immunogenicity and resistance to degradation, and methods for their preparation and use | Active | 03-Aug-2020 | ||
| US-20220119464-A1 | Protein inhibitors with reduced immunogenicity and resistance to degradation, and methods for their preparation and use | Active | 03-Aug-2020 | A61P31/14 |
Amide Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Amide Investors (5)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Engine Ventures | Venture Capital | Minority | ||
| Forcefield Venture | Venture Capital | Minority | ||
| Khosla Ventures | Venture Capital | Minority | ||
| The Engine | Accelerator/Incubator | |||
| Biological Engineering Ventures | Venture Capital | Minority |
Amide FAQs
-
When was Amide founded?
Amide was founded in 2016.
-
Where is Amide headquartered?
Amide is headquartered in Waltham, MA.
-
What is the size of Amide?
Amide has 10 total employees.
-
What industry is Amide in?
Amide’s primary industry is Biotechnology.
-
Is Amide a private or public company?
Amide is a Private company.
-
What is the current valuation of Amide?
The current valuation of Amide is .
-
What is Amide’s current revenue?
The current revenue for Amide is .
-
How much funding has Amide raised over time?
Amide has raised $16.5M.
-
Who are Amide’s investors?
Engine Ventures, Forcefield Venture, Khosla Ventures, The Engine, and Biological Engineering Ventures have invested in Amide.
-
Who are Amide’s competitors?
GenScript, Enamine, AnaSpec, and Polypeptide Laboratories are competitors of Amide.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
